Polydimethylsiloxane (PDMS) has a wide variety of commercial and industrial applications due to its mechanical and rheological properties in a range similar to the living tissues. In this study, we demonstrate that PDMS can be used to produce deformable microparticles to be integrated in the development of particulate blood analogue fluids. The difficulties associated with the use of in vitro blood make it necessary to perform in vitro experiments of blood flow with blood analogue fluids. However, an ideal analogue must match the rheology of blood at several points, and for that, blood analogue fluids should be a suspension of microparticles with similar properties (size, shape and flexibility) to blood cells, in particular to the red blood cells (RBCs). The microparticles used in this study were produced from a transparent PDMS with crosslinking ratios of 10:1, 8:2 and 6:4; from a black PDMS with a ratio of 1:1 and from a red-pigmented PDMS. Each PDMS microparticles sample was suspended in Dextran 40 to perform deformability assays and cell-free layer analysis in a hyperbolic-shaped microchannel and steady shear viscosity measurements in a rheometer. The proposed microparticles suspensions show a great potential to mimic the structural and rheological properties of RBC suspensions and consequently to develop blood analogue fluids with rheological properties similar to real blood.
View the article online for updates and enhancements. Related content PDMS droplet formation and characterization by hydrodynamic flow focusing technique in a PDMS square microchannel J Carneiro, E Doutel, J B L M Campos et al.-Simple and inexpensive microfluidic devices for the generation of monodisperse multiple emulsions
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.